NPHLA Intelligence
Clinical Trial Watch
Trials NPHLA follows, synchronised from ClinicalTrials.gov. We flag what matters (new registrations, changes in status and newly posted results) and ignore routine record edits. Every therapy in a trial is investigational.
- AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality
Cellese Inc.. Conditions: Skin Aging; Skin Quality. Investigational — not approved for the use studied.
- AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation
Cellese Inc.. Conditions: Skin Aging; Facial Rhytides; Skin Tone. Investigational — not approved for the use studied.
- A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Results posted 2026-09-25. Investigational — not approved for the use studied.
- MINOX: Treatment of Androgenetic Alopecia in Men for 24 Weeks
Eurofarma Laboratorios S.A.. Conditions: Alopecia. Investigational — not approved for the use studied.
- Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Pelage Pharmaceuticals, Inc.. Conditions: Androgenetic Alopecia. Results posted 2026-09-22. Investigational — not approved for the use studied.
- Treatment of Peyronie's Disease With Platelet-Rich Plasma
Herlev Hospital. Conditions: Peyronies Disease. Investigational — not approved for the use studied.
- Topical Rifamycin SV for Wound Healing After Sapphire FUE Hair Transplantation
Elif Asena KANTARCI. Conditions: Androgenetic Alopecia; Wound Healing. Investigational — not approved for the use studied.
- Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis
Universidad Nacional de Entre Rios. Conditions: Knee Osteoarthritis. Investigational — not approved for the use studied.
- Topical Multivitamin Serum for Skin Heath
Erevna Innovations Inc.. Conditions: Aesthetic. Investigational — not approved for the use studied.
- AGA: PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
Nanfang Hospital, Southern Medical University. Conditions: Androgenetic Alopecia (AGA). Investigational — not approved for the use studied.
- A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd.. Conditions: Moderate to Severe Glabellar Lines. Investigational — not approved for the use studied.
- Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
Fujian Medical University Union Hospital. Conditions: Androgenic Alopecia. Investigational — not approved for the use studied.
- AI-09 In Subjects With Glabellar Lines, GL-101
Eirion Therapeutics Inc.. Conditions: Glabellar Frown Lines. Results posted 2026-08-31. Investigational — not approved for the use studied.
- MMP US P3 416: A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
AbbVie. Conditions: Masseter Muscle Prominence. Investigational — not approved for the use studied.
- EXO-MINO: Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia
Tanta University. Conditions: Androgenetic Alopecia; Exosomes. Investigational — not approved for the use studied.
- MMP US P3 417: A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
AbbVie. Conditions: Masseter Muscle Prominence. Investigational — not approved for the use studied.
- Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
University of Florida. Conditions: Spasmodic Dysphonia. Results posted 2026-07-27. Investigational — not approved for the use studied.
- Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display
Al-Azhar University. Conditions: Excessive Gingival Display; Gingival Diseases; Gummy Smile; Esthetics, Dental. Investigational — not approved for the use studied.
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Trial listings are not recommendations to enrol or prescribe.